Patents by Inventor Masako Nozaki

Masako Nozaki has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD FOR INHIBITING TUMOR METASTASIS
    Publication number: 20190060278
    Abstract: A leukotriene C4 and D4 antagonist is used to inhibit tumor metastasis by acting to inhibit tumor cell adhesion to endothelial cells, thereby preventing tumor cell extravasation.
    Type: Application
    Filed: October 29, 2018
    Publication date: February 28, 2019
    Applicant: INFLAMMATION RESEARCH CENTER COMPANY LTD.
    Inventor: Masako NOZAKI
  • METHOD OF TREATING OR INHIBITING THE DEVELOPMENT OF BRAIN INFLAMMATION AND SEPSIS
    Publication number: 20180140580
    Abstract: A leukotriene C4 and D4 antagonist is used to treat or inhibit brain inflammation and sepsis by acting to inhibit increased capillary permeability and white blood cell extravasation. Potential candidate compounds can be screened in a non-human mammal before or after administration of an inflammation inducing agent into the subarachnoid space by determining their ability to inhibit increased capillary permeability and white blood cell extravasation.
    Type: Application
    Filed: October 23, 2017
    Publication date: May 24, 2018
    Inventor: Masako Nozaki
  • METHOD FOR INHIBITING TUMOR METASTASIS
    Publication number: 20170014384
    Abstract: A leukotriene C4 and D4 antagonist is used to inhibit tumor metastasis by acting to inhibit tumor cell adhesion to endothelial cells, therby preventing tumor cell extravasation.
    Type: Application
    Filed: February 16, 2016
    Publication date: January 19, 2017
    Inventor: Masako Nozaki
  • METHOD OF TREATING OR INHIBITING THE DEVELOPMENT OF BRAIN INFLAMMATION AND SEPSIS
    Publication number: 20170007577
    Abstract: A leukotriene C4 and D4 antagonist is used to treat or inhibit brain inflammation and sepsis by acting to inhibit increased capillary permeability and white blood cell extravasation. Potential candidate compounds can be screened in a non-human mammal before or after administration of an inflammation inducing agent into the subarachnoid space by determining their ability to inhibit increased capillary permeability and white blood cell extravasation.
    Type: Application
    Filed: September 19, 2016
    Publication date: January 12, 2017
    Inventor: Masako Nozaki
  • Method for Inhibiting Tumor Metastasis
    Publication number: 20080206203
    Abstract: A leukotriene C4 and D4 antagonist is used to inhibit tumor metastasis by acting to inhibit tumor cell adhesion to endothelial cells, thereby preventing tumor cell extravasation.
    Type: Application
    Filed: July 14, 2005
    Publication date: August 28, 2008
    Applicant: Inflammation Research Center Company Ltd.
    Inventor: Masako Nozaki
  • METHOD OF TREATING OR INHIBITING THE DEVELOPMENT OF BRAIN INFLAMMATION AND SEPSIS
    Publication number: 20070066649
    Abstract: A leukotriene C4 and D4 antagonist is used to treat or inhibit brain inflammation and sepsis by acting to inhibit increased capillary permeability and white blood cell extravasation. Potential candidate compounds can be screened in a non-human mammal before or after administration of an inflammation inducing agent into the subarachnoid space by determining their ability to inhibit increased capillary permeability and white blood cell extravasation.
    Type: Application
    Filed: November 1, 2006
    Publication date: March 22, 2007
    Inventor: Masako Nozaki
  • METHOD OF TREATING OR INHIBITING THE DEVELOPMENT OF BRAIN INFLAMMATION AND SEPSIS
    Publication number: 20070066648
    Abstract: A leukotriene C4 and D4 antagonist is used to treat or inhibit brain inflammation and sepsis by acting to inhibit increased capillary permeability and white blood cell extravasation. Potential candidate compounds can be screened in a non-human mammal before or after administration of an inflammation inducing agent into the subarachnoid space by determining their ability to inhibit increased capillary permeability and white blood cell extravasation.
    Type: Application
    Filed: November 1, 2006
    Publication date: March 22, 2007
    Inventor: Masako NOZAKI
  • METHOD OF TREATING OR INHIBITING THE DEVELOPMENT OF BRAIN INFLAMMATION AND SEPSIS
    Publication number: 20070060611
    Abstract: A leukotriene C4 and D4 antagonist is used to treat or inhibit brain inflammation and sepsis by acting to inhibit increased capillary permeability and white blood cell extravasation. Potential candidate compounds can be screened in a non-human mammal before or after administration of an inflammation inducing agent into the subarachnoid space by determining their ability to inhibit increased capillary permeability and white blood cell extravasation.
    Type: Application
    Filed: November 1, 2006
    Publication date: March 15, 2007
    Inventor: Masako Nozaki
  • METHOD OF TREATING OR INHIBITING THE DEVELOPMENT OF BRAIN INFLAMMATION AND SEPSIS
    Publication number: 20070059243
    Abstract: A leukotriene C4 and D4 antagonist is used to treat or inhibit brain inflammation and sepsis by acting to inhibit increased capillary permeability and white blood cell extravasation. Potential candidate compounds can be screened in a non-human mammal before or after administration of an inflammation inducing agent into the subarachnoid space by determining their ability to inhibit increased capillary permeability and white blood cell extravasation.
    Type: Application
    Filed: November 1, 2006
    Publication date: March 15, 2007
    Inventor: Masako Nozaki
  • METHOD OF TREATING OR INHIBITING THE DEVELOPMENT OF BRAIN INFLAMMATION AND SEPSIS
    Publication number: 20070054937
    Abstract: A leukotriene C4 and D4 antagonist is used to treat or inhibit brain inflammation and sepsis by acting to inhibit increased capillary permeability and white blood cell extravasation. Potential candidate compounds can be screened in a non-human mammal before or after administration of an inflammation inducing agent into the subarachnoid space by determining their ability to inhibit increased capillary permeability and white blood cell extravasation.
    Type: Application
    Filed: November 1, 2006
    Publication date: March 8, 2007
    Inventor: Masako NOZAKI
  • Method of treating or inhibiting the development of brain inflammation and sepsis
    Patent number: 7148248
    Abstract: A leukotriene C4 and D4 antagonist is used to treat or inhibit brain inflammation and sepsis by acting to inhibit increased capillary permeability and white blood cell extravasation. Potential candidate compounds can be screened in a non-human mammal before or after administration of an inflammation inducing agent into the subarachnoid space by determining their ability to inhibit increased capillary permeability and white blood cell extravasation.
    Type: Grant
    Filed: November 26, 2003
    Date of Patent: December 12, 2006
    Inventor: Masako Nozaki
  • Method of treating or inhibiting the development of brain inflammation and sepsis
    Publication number: 20040167161
    Abstract: A leukotriene C4 and D4 antagonist is used to treat or inhibit brain inflammation and sepsis by acting to inhibit increased capillary permeability and white blood cell extravasation. Potential candidate compounds can be screened in a non-human mammal before or after administration of an inflammation inducing agent into the subarachnoid space by determining their ability to inhibit increased capillary permeability and white blood cell extravasation.
    Type: Application
    Filed: November 26, 2003
    Publication date: August 26, 2004
    Inventor: Masako Nozaki